Can you elaborate on what you’ve learned? T.i.a. Dew
Well, nothing more than that one should not believe in what the company says and that the "oncology space" is evolving rapidly... Having said that, I think OXGN at the current MC is undervalued and worthy of a small speculative investment.
Market Data 
Markets 
AI
